| abstract |
A novel C-phenyl glucitol compound capable of preventing or treating diabetes by inhibiting both SGLT1 activity and SGLT2 activity, exhibiting glucose absorption inhibition from the digestive tract and urinary glucose excretion. The present invention provides a preventive / therapeutic agent for diabetes, containing as an active ingredient. The following formula (I) [In formula (I), Y is a C 1-6 alkylene group, etc., Z is —CONHR A (wherein R A is a hydroxyl group, etc.), etc. ] The preventive or therapeutic agent of diabetes which uses the C-phenyl glucitol compound or its salt, hydrate represented by these as an active ingredient. [Selection figure] None |